Lineage Cell Therapeutics, a clinical-stage biotechnology company, has announced that the Company has initiated the DOSED (Delivery of Oligodendrocyte Progenitor Cells (OPCs) for Spinal Cord Injury: Evaluation of a Novel Device) clinical study.
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
4basebio has announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Likarda announced a new grant from the Gates Foundation that supports the company’s proprietary Core-Shell Spherification (CSS) system to extend the therapeutic potential of a cost-effective cell-based therapy for infectious diseases.
Harvey Branton, senior translational consultant at cell and gene therapy CDMO eXmoor Pharma, shares insights into early process development, exploring common misconceptions that could impact long-term manufacturing success for ATMP developers.
Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has completed its latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland.
Patent-filing research conducted by Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising treatments for various forms of cancer is nearing.
SGS has announced the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry.
Astraveus SAS, the Benchtop Cell Factory company, has announced the "first ever successful" end-to-end production of CAR-T cells within a microfluidic benchtop system.
